Abstract:Hepatocellular carcinoma (HCC) is one of the most heterogeneous malignant cancers with no effective targets and treatments. However, the molecular pathogenesis of HCC remains largely uncertain. The aims of our study were to find crucial genes involved in HCC through multidimensional methods and revealed potential molecular mechanisms. Here, we reported the gene expression profile GSE121248 findings from 70 HCC and 37 adjacent normal tissues, all of which had chronic hepatitis B virus (HBV) infection, we were seeking to identify the dysregulated pathways, crucial genes and therapeutic targets implicated in HBV-associated HCC. We found 164 differentially expressed genes (DEGs) (92 downregulated genes and 72 upregulated genes). Gene ontology (GO) analysis of DEGs revealed significant functional enrichment of mitotic nuclear division, cell division, and the epoxygenase P450 pathway. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the DEGs were mainly enriched in metabolism, cell cycle regulation and the p53 signaling pathway. The Mcode plugin was calculated to construct a module complex of DEGs, and the module was mainly enriched in cell cycle checkpoints, RHO GTPase effectors and cytochrome P450. Considering a weak contribution of each gene, gene set enrichment analysis (GSEA) was performed, revealing results consistent with those described above. Six crucial proteins were selected based on the degree of centrality, including NDC80, ESR1, ZWINT, NCAPG, ENO3 and CENPF. Real-time quantitative PCR analysis validated the six crucial genes had the same expression trend as predicted. Furthermore, the methylation data of The Cancer Genome Atlas (TCGA) with HCC showed that mRNA expression of crucial genes was negatively correlated with methylation levels of their promoter region. The overall survival reflected that high expression of NDC80, CENPF, ZWINT, and NCAPG significantly predicted poor prognosis, whereas ESR1 high expression exhibited a favorable prognosis. The identification of the crucial genes and pathways would contribute to the development of novel molecular targets and biomarker-driven treatments for HCC.

Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Insights into Significant Pathways and Gene Interaction Networks in Peripheral Blood Mononuclear Cells for Early Diagnosis of Hepatocellular Carcinoma.

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Identification of Gene Expression Profiling in Hepatocellular Carcinoma Using Cdna Microarrays

Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma

Immune Classifier-Based Signatures Provide Good Prognostic Stratification and Predict the Clinical Benefits of Immune-Based Therapies for Hepatocellular Carcinoma

Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma

A Blood-Based 22-Gene Expression Signature for Hepatocellular Carcinoma Identification

Discovery and Analysis of Hepatocellular Carcinoma Genes Using Cdna Microarrays

Screening and validation of tumor-associated genes in human hepatocellular carcinoma tissues.

Identification of Crucial Genes Based on Expression Profiles of Hepatocellular Carcinomas by Bioinformatics Analysis.

Expression Profile Reveals Novel Prognostic Biomarkers in Hepatocellular Carcinoma.

Identification of prognosis-related genes in hepatocellular carcinoma based on bioinformatical analysis

Combined Use of Laser Capture Microdissection and Gene Microchip Technigues for Differential Expression Gene Screening in Hepatocellular Carcinoma

Identification of Candidate Diagnostic Tumor Markers for Human Hepatocellular Carcinoma Using Genechip Technology

Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma

Identification of Hepatocellular Carcinoma-associated Hub Genes and Pathways by Integrated Microarray Analysis

Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma